# Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia

> **NCT06488794** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **University Hospital Fattouma Bourguiba** · enrollment: 400 (estimated)

## Conditions studied

- Ventilator Associated Pneumonia

## Interventions

- **DRUG:** colistimethate sodium
- **DRUG:** 0.9% Saline

## Key facts

- **NCT ID:** NCT06488794
- **Lead sponsor:** University Hospital Fattouma Bourguiba
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-02-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06488794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06488794, "Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06488794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*